2.5.1 Detection of DRPs
The
Detection of DRPs was the first outcome. The pharmacists were required
to work as usual, using their professional knowledge to evaluate
medication therapies. The DRPs were classified by the pharmacists who
performed the medication reviews. The DRPs were recorded after
evaluating the indication, dosage, adherence, adverse reactions, and
therapeutic effects of each medication. It was recommended to optimize
patients’ drug therapy by the pharmacists. The DRPs and recommendations
were evaluated using The Pharmaceutical Care Network Europe (PCNE)
Classification for Drug related problems V8.03 regarding problem,
causes, planned interventions and intervention acceptance [15].
2.5.2Clinical
outcomes and cost‐saving effect
The clinical outcomes and cost-saving effect were the secondary
endpoints and compared on the first visit date (baseline) and the end of
follow-up. The outcomes of BP was mean diastolic blood pressure (DBP)/
systolic blood pressure (SBP) of hypertensive patients on every visit.
The outcomes of lipids was concluded
total cholesterol (TC),
low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG). The
cost-saving effect outcome was average costs of medications per patient
for every month. The drug costs were standardized over the study period.